Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novartis AG Common Stock
(NY:
NVS
)
150.55
+1.40 (+0.94%)
Streaming Delayed Price
Updated: 3:11 PM EDT, May 19, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Novartis AG Common Stock
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
The Healthcare Companies Fighting the World’s Biggest Killers
July 13, 2022
Palm Beach, FL – July 13, 2022 – FinancialNewsMedia.com News Commentary – Some of the most prevalent health conditions on the planet claim millions of lives every year. Companies from across the...
Via
FinancialNewsMedia
Liposome Drug Delivery Market Size, Share, Key Players Analysis, Growth Factors, New Technology, Application and Regional Forecast to 2028
July 08, 2022
Global Liposome Drug Delivery Market Size was estimated at USD 3316.64 million in 2021 and is projected to reach USD 7768.01 million by 2028, exhibiting a CAGR of 12.93% during the forecast period
Via
SBWire
Dry Eye Syndrome Treatment Market Size, Share, Key Players Analysis, Growth Factors, New Technology, Application and Regional Forecast to 2028
July 06, 2022
Global Dry Eye Syndrome Treatment Market Size was estimated at USD 3062.77 million in 2021 and is projected to reach USD 3959.59 million by 2028, exhibiting a CAGR of 3.74% during the forecast period
Via
SBWire
Global PCSK9 Inhibitors Market |Key players are Amgen, Eli Lilly, Sanofi, Pfizer, Novartis, Roche, Merck, Alnylam, AstraZeneca, Affiris, BMS, Ionis Pharmaceuticals, Cyon Therapeutics, and Daiichi Sankyo.
July 06, 2022
Global PCSK9 Inhibitors Market |Key players are Amgen, Eli Lilly, Sanofi, Pfizer, Novartis, Roche, Merck, Alnylam, AstraZeneca, Affiris, BMS, Ionis Pharmaceuticals, Cyon Therapeutics, and Daiichi...
Via
iCrowdNewswire
Antifungal Drugs Market Import-Export Details, Production Information 2022-2029 : Sanofi-Aventis, Novartis, Pfizer Inc, Abbott Laboratories
July 05, 2022
Global Antifungal Drugs Market Research 2022-2031 published by Calibre Research studies the current situation, Antifungal Drugs market size, share, trends, regional growth and the latest technologies...
Via
SBWire
Topics
Supply Chain
Cough Remedies Market 2022-2029 Global Industry Trends, Growth Rate and Revenue : Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis
June 30, 2022
Global Cough Remedies Market Research 2022-2031 published by Calibre Research studies the current situation, Cough Remedies market size, share, trends, regional growth and the latest technologies...
Via
SBWire
Topics
Supply Chain
Tigecycline Market Development Factors 2022-2029 Pfizer, Hisun Pharma, Hansoh Pharma, HICIN Pharma, Amgen
June 27, 2022
Global Tigecycline Market Research 2022-2031 published by Calibre Research studies the current situation, Tigecycline market size, share, trends, regional growth and the latest technologies utilized by...
Via
SBWire
Topics
Supply Chain
Global Interferon Beta Drugs Market | Key Players are Biogen, Merck, Novartis, Bayer, Faron Pharmaceuticals, and other prominent players
June 23, 2022
Global Interferon Beta Drugs Market | Key Players are Biogen, Merck, Novartis, Bayer, Faron Pharmaceuticals, and other prominent players The market size of the Global Interferon Beta Drugs Market in...
Via
iCrowdNewswire
Global Radioligand Therapy Market | Key Players are Johnson & Johnson Services, Inc., Pfizer Inc., Bayer AG, Molecular Partners, ITM Isotope Technologies Munich SE, Amneal Pharmaceuticals LLC, Novartis International AG and many more.
June 23, 2022
Global Radioligand Therapy Market | Key Players are Johnson & Johnson Services, Inc., Pfizer Inc., Bayer AG, Molecular Partners, ITM Isotope Technologies Munich SE, Amneal Pharmaceuticals LLC, Novartis...
Via
iCrowdNewswire
NYSE:NVS Investor Alert: Investigation over Possible Securities Laws Violations by Novartis AG
↗
June 17, 2022
San Diego, CA -- (SBWIRE) -- 06/17/2022 -- Novartis AG is under investigation concerning potential securities laws violations in connection with certain financial statements.
Via
SBWire
Crews Control Names Barbara Kittridge President, Andrea Keating Moves to CEO
June 09, 2022
Crews Control promotes Barbara Kittridge to President.
Via
Newswire.com
2021 R&D Spending and Intensity Benchmarks
June 06, 2022
VIRGINIA BEACH, Va. - June 6, 2022 - PRLog -- According to a newly released study from Schonfeld & Associates, Inc., R&D Ratios & Budgets, the pharmaceutical industry continued to be the biggest R&D...
Via
PRLog
Topics
Supply Chain
NOVARTIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Novartis AG on Behalf of Novartis Stockholders and Encourages Investors to Contact the Firm
June 02, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
New effort to standardize cardiovascular care in Mexico, address gaps in care
June 02, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
NOVARTIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Novartis AG on Behalf of Novartis Stockholders and Encourages Investors to Contact the Firm
June 01, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Novartis AG (NVS) on Behalf of Investors
June 01, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Novartis AG (NVS) on Behalf of Investors
May 31, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Novartis AG (NVS) on Behalf of Investors
May 31, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Global Central Nervous System Treatment Market Is Expected to Reach $166 Billion In 2028
May 26, 2022
Palm Beach, FL – May 26, 2022 – FinancialNewsMedia.com News Commentary – Worldwide, there is a rapid increase in the prevalence and incidence of neurological disorders such as multiple sclerosis,...
Via
FinancialNewsMedia
Online shop Etalaze announces shift to a new domain www.Etalaze.biz
May 20, 2022
Via
AB Newswire
Pain Management Drugs Market Increased Research Activities Boost Demand Opportunities
May 17, 2022
Pain Management Drugs Market Increased Research Activities Boost Demand Opportunities The global pain management drugs market was valued at $71,431.85 million in 2019, and is projected to reach...
Via
iCrowdNewswire
Asia-Pacific Anti-Inflammatory Therapeutics Market Qualitative Insights on Application & Outlook by Share, Future Growth
May 16, 2022
Asia-Pacific Anti-Inflammatory Therapeutics Market Qualitative Insights on Application & Outlook by Share, Future Growth Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR...
Via
iCrowdNewswire
Topics
Intellectual Property
Surgical Equipment Market Top Companies, Business Growth & Investment Opportunities, Share
May 12, 2022
Surgical Equipment Market Top Companies, Business Growth & Investment Opportunities, Share The global surgical equipment market valued at $31,722.30 million in 2019 and is estimated to reach $44,448.58...
Via
iCrowdNewswire
Setareh Williams Joins Cobbs Creek Healthcare as Managing Partner/Head of Real-World Evidence and Scientific Communications
May 04, 2022
Cobbs Creek Healthcare Expanding Into RWE/HEOR Area
Via
Newswire.com
Rancho Biosciences Launches the Single Cell Data Science Consortium With Four Charter Members
May 02, 2022
Rancho Biosciences, a leading company in the field of data curation and data services, is pleased to announce the launch of its Single Cell Data Science (SCDS) pre-competitive consortium. The...
Via
Newswire.com
HITLAB Announces Trutag and Vicert as Sponsors for April 2022 Digital Health Symposium
April 20, 2022
HITLAB is pleased to announce TruTag Technologies and Vicert as official sponsors for its upcoming digital symposium. The April 28th virtual event is focused on health tech adoption for clinicians,...
Via
PRUnderground
Rx Holdings Acquires Biocel Access Solutions
March 31, 2022
A Strategic Initiative That Taps Into the $8.4 Billion Affordability Market
Via
Newswire.com
Pharmacovigilance (PV) Outsourcing Market Size, Share, Trends, Industry Analysis, Growth and Forecast 2022-2028
March 23, 2022
Pharmacovigilance (PV) Outsourcing Market 2022-2028, Segmentation, Swot Analysis including Key Players like – Accenture, C3i Solutions, Clintec, Covance, ELC Group, Ergomed, IQVIA, Novartis, Parexel
Via
SBWire
Diabetic Kidney Disease Market to Witness Upsurge in Growth During the Forecast Period – DelveInsight | Key Players – Bayer, Reata Pharma, Novartis, Dimerix, Kyowa Kirin, Gilead, Orbsen, and Others
March 10, 2022
Continue reading "Diabetic Kidney Disease Market to Witness Upsurge in Growth During the Forecast Period – DelveInsight | Key Players – Bayer, Reata Pharma, Novartis, Dimerix, Kyowa Kirin, Gilead,...
Via
Get News
Renewable Energy Investment Market Size, Share, Trends, Industry Growth, and Forecast 2028 Top Key Players Spectrum, Roche, Pfizer, Novartis, Merck, Bayer, Healthcare Amgen
March 01, 2022
Renewable Energy Investment Market Size, Share, Growth, Industry Trends, Business Scope, Global Providers, COVID-19 Impact and Forecast 2028
Via
SBWire
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.